PEGFILGRASTIM-CBQV

1434 reported adverse events

Drug classes: Leukocyte Growth Factor [EPC]

These side effects are most commonly reported by patients taking PEGFILGRASTIM-CBQV:

# Side effect Count
0 DEVICE MALFUNCTION 915
1 NO ADVERSE EVENT 715
2 PRODUCT DOSE OMISSION ISSUE 159
3 DEATH 99
4 ACCIDENTAL EXPOSURE TO PRODUCT 39
5 DEVICE FAILURE 38
6 PRODUCT LABEL CONFUSION 36
7 NEUTROPHIL COUNT DECREASED 30
8 DEVICE LEAKAGE 24
9 BONE PAIN 21
See all common reactions for PEGFILGRASTIM-CBQV

PEGFILGRASTIM-CBQV is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION) 1 0.0526
1 LUNG SQUAMOUS CELL CARCINOMA STAGE IV 1 0.0149
2 WRONG PRODUCT STORED 4 0.0141
3 DEVICE MALFUNCTION 915 0.0130
4 APPLICATION SITE INDURATION 2 0.0118
5 RHABDOMYOSARCOMA 2 0.0106
6 DEVICE INTOLERANCE 2 0.0084
7 ENDOMETRIAL CANCER RECURRENT 1 0.0076
8 GLOMERULAR VASCULAR DISORDER 1 0.0067
9 PRODUCT PACKAGING CONFUSION 16 0.0066
See all enriched reactions for PEGFILGRASTIM-CBQV